Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medicare Part D Catastrophic Spending Surge Needs Solutions, OIG Says

06 Jan 2017

• By Cathy Kelly

Silhouette-Seniors-In-Pills_1200x675

Related Content

Medicare Part D Cost Trends: A Good News/Bad News Story For Biopharma

03 Aug 2016

Part D Reform Proposals From MedPAC May Find Traction After Election

16 Jun 2016

Related Companies

Gilead Sciences, Inc.

Astellas Pharma, Inc.

Pfizer Inc.

Additional Topics

United States Pricing Debate Reimbursement

More from Medicare

More from Government Payers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.